Medical College, University of Rzeszow, Rzeszow, Poland.
Departament of Maxillofacial Surgery, Fryderyk Chopin Clinical State Hospital, Rzeszow, Poland.
BMC Oral Health. 2021 Jan 15;21(1):31. doi: 10.1186/s12903-021-01391-9.
Patients using antiplatelet drugs following infarctions, acute coronary syndrome or stroke pose a significant clinical problem if it is necessary to perform surgery, including dental surgery, since they are at risk of prolonged or secondary post-extraction bleeding. Discontinuation of this therapy is associated with a high risk of serious thromboembolic complications. The purpose of this study was to assess the effectiveness of TachoSil fibrin-collagen patches in stopping and preventing of secondary post-extraction bleeding in patients undergoing chronic antiplatelet therapy.
The study was conducted through retrospective examination of the medical records of 153 patients using chronic antiplatelet therapy and those qualified for tooth extraction. The largest group comprised 74 patients using aspirin and clopidogrel as dual platelet antiaggregation therapy; in this group 75 tooth extractions were carried out. In all of the patients TachoSil fibrin-collagen patches and stiches were applied to the wounds resulting from tooth removal.
Following tooth extraction, primary bleeding was stopped in all the patients and their wounds closed via coagulation within 20-30 min. In eight cases, accounting for 4.9% of the patients, secondary bleeding occurred and was successfully stopped only by applying a pressure dressing soaked in tranexamic acid. Secondary bleeding occurred in three patients on the second day and in five patients on the third day following tooth removal.
Topical application of TachoSil patches following tooth removal in patients using single or dual antiplatelet therapy effectively stopped bleeding and prevented secondary bleeding after tooth extraction.
对于正在服用抗血小板药物(如发生过梗死、急性冠脉综合征或中风)的患者,如果需要进行手术(包括牙科手术),则存在显著的临床问题,因为他们有发生延长或继发性拔牙后出血的风险。停止这种治疗与严重血栓栓塞并发症的高风险相关。本研究的目的是评估 TachoSil 纤维蛋白-胶原蛋白贴在停止和预防接受慢性抗血小板治疗的患者继发性拔牙后出血方面的有效性。
该研究通过对 153 名接受慢性抗血小板治疗且符合拔牙条件的患者的病历进行回顾性检查进行。最大的一组包括 74 名接受阿司匹林和氯吡格雷作为双重血小板抗聚集治疗的患者;在该组中进行了 75 次拔牙。在所有患者中,均应用 TachoSil 纤维蛋白-胶原蛋白贴和缝线对拔牙后产生的伤口进行处理。
拔牙后,所有患者的原发性出血均停止,其伤口在 20-30 分钟内通过凝血闭合。在 8 例(占患者的 4.9%)中,继发性出血发生,仅通过应用浸有氨甲环酸的加压敷料才成功止血。继发性出血发生在 3 例患者的拔牙后第二天,发生在 5 例患者的拔牙后第三天。
在接受单一或双重抗血小板治疗的患者中,拔牙后应用 TachoSil 贴片可有效止血,并预防拔牙后的继发性出血。